Category: cervical cancer

HPV Vaccine: Is It Even Worth It?

April 25, 2023
adverse reactionsanal cancerautoimmune diseasecalifornia bill 659cancercancer prevention actCecilia Aguiar-Currycervical cancerchildhood vaccinesDr. John LittellEpochTVFrontline HealthGardasilgardasil 9health carehomosexualityHPV vaccinehpv4hpv9human papillomavirusLifeStyle & Learninglong COVIDlong haulLupusmerckneurological diseasepenile cancersexually transmitted virusstithroat cancervaccine safetyvaccine schedule
0 Comment

California just passed a health bill that aims to increase vaccination rates in schools and colleges against a sexually transmitted virus.  Lawmakers believe vaccination against HPV, or the human papillomavirus, will help reduce the risk of rare cancers five to 20 years down the line. But many parents are calling the bill deceptive. Testimonies during…

Read More

Can HPV Vaccine Prevent Cervical Cancer: Current Studies (Part 3)

January 21, 2023
cervical cancerclinical trialHPV vaccineUncategorizedvaccinationwomen
0 Comment

In part 1 and part 2 of this series, we discussed the HPV vaccine and its links to ovarian insufficiency and autoimmune disease. In part 3, we turn to questions regarding the effectiveness of the vaccine to prevent cervical cancer, and the limitations of relevant clinical trials to detect such a type of effect. Summary…

Read More

Quebec to Use HPV Test to Screen for Cervical Cancer, Replacing Pap Test

May 31, 2022
Canadacervical cancerHPVpap testQuebecWorld
0 Comment

Quebec says it will start using human papillomavirus tests as its primary screening tool for cervical cancer, replacing the Pap smear. The Health Department says the province will systematically offer HPV testing for cervical cancer screening to all women aged 25 to 65, every five years. A government health-care research institute said in a January…

Read More

AstraZeneca’s Imfinzi Fails Main Goal in Advanced Cervical Cancer Study

March 25, 2022
antibodiesAstrazenecaBusiness & Economycervical cancerCompanieslung cancer
0 Comment

AstraZeneca said on Thursday its drug Imfinzi, along with chemoradiotherapy, failed to achieve the main goal of improving survival in patients with locally advanced cervical cancer without the disease worsening. The late-stage study, dubbed “CALLA,” tested progression-free survival of patients with the combination against chemoradiotherapy alone, the drugmaker said, and the results are seen as…

Read More